Holox is a leading big data service provider specializing in pharmacovigilance (PV) and drug safety solutions for the pharmaceutical industry. Founded in 2016 and headquartered in Beijing, the company operates a comprehensive SaaS platform designed to help pharmaceutical companies, clinical research organizations (CROs), and regulatory bodies manage drug safety data, monitor adverse events, and ensure global regulatory compliance. The company's proprietary technology stack includes four specialized platforms: Holox® Clinical, Holox® Pharma, Holox® Vaccin, and Holox® RWE (Real World Evidence). These platforms provide end-to-end services including automated report collection, pharmaceutical data analysis, safety risk warnings, Periodic Safety Update Reports (PSUR), and international industry standard queries. Holox leverages artificial intelligence and neural networks to provide intelligent signal detection and risk mitigation, positioning itself as a critical infrastructure provider for the modern drug development lifecycle.
CLASSIFICATION
Company Type:Digital Health
Industry:Digital Health
Sub-Industry:Pharmacovigilance SaaS & Big Data
SIZE & FINANCIALS
Employees:51-200
Revenue:$10M-$50M
Founded:2016
Ownership:private
Status:operating
FUNDING
Stage:Series A+
Total Raised:$20M-$50M (estimated)
Investors:CCB International, Z&H Investment
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Software/Service Provider)
Modalities:Small molecule, Biologics, Vaccines, Cell & Gene Therapy
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Science/AAAS (International collaboration and publishing), Various Chinese domestic pharmaceutical leaders for PV compliance, Strategic AIoT partnership in Dubai (2025)
COMPETITION
Position:Emerging
Competitors:IQVIA, Veeva Systems, ArisGlobal, Oracle (Argus Safety), Taimei Technology
LEADERSHIP
Key Executives:
Xiaoying Chu - Director of Global Collaboration
LINKS
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Holox and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Holox. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.